Featured News

Looking for the perfect holiday gift for your loved one with celiac disease? Look no further than our Team Gluten-Free shop! We have shirts, hats, and more. 

Today is #GivingTuesday, the National Day of Giving! Join the movement and give a gift that improves the lives of those suffering from celiac disease. No gift is too small.

The Celiac Disease Foundation wishes our community a healthy and happy Thanksgiving! We are thankful for you and hope you enjoy a wonderful holiday with friends, family, and all your gluten-free favorites.

Within the last year, at least three studies were conducted with the goal of determining the relationship between the amount of gluten ingested and the risk of developing celiac disease. An important review of these studies, conducted by Jonas Ludvigsson and CDF Research Committee Member Benjamin Lebwohl, concluded that new clinical trials must be conducted…

Researchers at the Beth Israel Deaconess Medical Center, including Celiac Disease Foundation Medical Advisory Board Member Dan Leffler, conducted a study to determine the effects of the gluten-free diet (GFD) on weight changes in celiac patients after diagnosis. The authors note that while weight gain would be welcome and expected in initially underweight patients, similar…

Scientist at Cincinnati Children’s Hospital awarded $1.5 million grant to study stem cells from patients with genetic diseases, including celiac disease, that impair one’s ability to properly absorb nutrients to help develop new therapies for malnutrition.

On November 2, 2019, supporters of all ages put on their running shoes & joined us for the Celiac Disease Foundation Team Gluten-Free Turkey Trot 5K Fun Run/Walks in New York, Los Angeles, Princeton, & Orange County.

We put together a list of some of the most common perceived barriers to participating in clinical trials, and how to overcome them.

Cour Pharmaceuticals has announced a $420 million licensing deal with Takeda Pharmaceuticals following a favorable outcome of their phase 2 trial for celiac disease. The company released data from a small phase 2a study at the annual United European Gastroenterology organization meeting showing that its treatment, CNP-101, cut levels of inflammation-promoting cytokines. The technology was…

Don’t let gluten spook you this Halloween! Snack safely with our Gluten-Free Halloween Candy List.